Device Trial Radar · NCT07621172
Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects
Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Feb 3, 2020
Primary completion
Apr 27, 2021
Study completion Apr 27, 2021
Sponsor
- Lead sponsor
- Cellontech Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 2, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 19 years, up to 70 years
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to evaluate the safety and efficacy of CartiFill implanted at the site of knee joint cartilage defect in a 6-year, long-term, follow-up investigation.
Conditions
- Cartilage Defects of the Knee
Interventions
CartiFillDevice
add collagen when doing microfracture
MicrofractureProcedure
simple microfracture of ankle
Primary outcomes
What the sponsor says the trial is designed to measure.
- 100mm VAS (visual analogue scale) scoreTime frame: From screening to 6 years (±1 year) after surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.